This review summarizes commercially available whole blood methods for monitoring primary hemostasis during drug-mediated anticoagulation.
May guide monitoring tool selection in anticoagulation; leaves open prospective validation of clinical utility.
This article provides an overview on current commercially available methods to determine primary haemostasis as a target of drug-mediated anticoagulation. It focuses on whole blood methods only, and references the currently major achievements that have been reported with each method in respect to its clinical use. Advantages and disadvantages of the various methods are presented, based on considerations of platelet physiology, and on feasibility of the procedures.
No takes yet. Share an insight, caveat, or question.
Calatzis et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: